Spring for STEM

Spring for STEM

Spring for STEM

Spring for STEM

Spring for STEM

Spring for STEM

Spring for STEM

April 11, 2019

Gene Editing and the Future of Disease: The CRISPR Revolution


About Spring for STEM

NYSCI’s fifth annual Spring for STEM will offer a deep dive into the revolution of bioengineering and genetics being made possible with CRISPR gene editing technology, led by a panel of experts who will guide us through the policy and ethical implications of CRISPR on global health.

Spring for STEM provides a distinctive platform for presenting critical issues to people interested in science, education, and the cultural and intellectual life of New York. We are proud to host this annual invitation-only event that highlights various perspectives on STEM learning and creativity, while keeping NYSCI’s unique Design, Make, Play approach at the heart of the conversation.

For more information, please contact us at 718-595-9180 or presidentscouncil@nysci.org.

Cosmopolitan Club
122 East 66th Street • New York, N.Y.

(business formal dress)
 

RECEPTION

5 pm
 

PANEL DISCUSSION with Q&A

6 pm

Robbie Barbero – Panelist
Chief Business Officer
Ceres Nanosciences

Kevin Esvelt – Panelist
Assistant Professor of Media Arts & Sciences
MIT Media Lab

Rachel Haurwitz – Panelist
President and CEO
Caribou Biosciences

Sharon Begley – Moderator
Senior Writer, Science & Discovery
STAT News

 

DINNER & PRESENTATION OF DESIGN, MAKE, PLAY AWARD

7 pm

Panelists

Robbie Barbero

As the chief business officer at Ceres Nanosciences, Robbie works with the CEO and the rest of the team to drive business growth by supporting key product development programs and identifying new technology commercialization and industry partnership opportunities.

Robbie received his doctorate in biological engineering from MIT, where he received various awards, including being named an MIT Presidential Fellow and a Siebel Scholar. Before graduate school, Robbie spent five years working for three biotechnology startups – GlycoFi (acquired by Merck), Quantum Dot Corporation (acquired by Invitrogen), and Nanostream.

Prior to joining Ceres, Robbie was the assistant director of biological innovation in the White House Office of Science and Technology Policy where he spent more than four years developing and implementing policy on global and national life science issues.

Kevin Esvelt

Kevin M. Esvelt is an assistant professor of the MIT Media Lab, where he leads the Sculpting Evolution Group in exploring evolutionary and ecological engineering.

In 2013, Esvelt was the first to identify the potential for CRISPR “gene drive” systems to alter wild populations of organisms. Recognizing the implications of an advance that could enable individual scientists to alter the shared environment, he and his colleagues chose to break with scientific tradition by revealing their findings and calling for open discussion and safeguards before they demonstrated the technology in the laboratory.

His work is frequently published in top scientific journals, including Nature and Science, and covered in The New York Times, The New Yorker, The Atlantic, PBS NOVA and NPR.

Rachel Haurwitz

Rachel is a co-founder of Caribou Biosciences and has been president and CEO since its inception in 2011. She has a research background in CRISPR-Cas biology and is also a co-founder of Intellia Therapeutics.

Rachel is an inventor on several patents and patent applications covering multiple CRISPR-based technologies, and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems.

In 2014, she was named by Forbes Magazine to the “30 Under 30” list in science and healthcare, and in 2016, Fortune Magazine named her to the “40 Under 40” list of the most influential young people in business. In 2018, the Association for Women in Science recognized Rachel with the annual Next Generation Award.

Sharon Begley

Sharon Begley is the senior science writer at STAT, the life sciences publication of the Boston Globe. Previously she was the senior health and science correspondent at Reuters, the science editor and science columnist at Newsweek, and the science columnist at The Wall Street Journal.

Sharon is the recipient of numerous awards for her writing, including an honorary degree from the University of North Carolina at Asheville for communicating science to the public, the Public Understanding of Science Award from the San Francisco Exploratorium, and the Victor Cohn prize. She has spoken before many audiences about science writing, neuroplasticity and science literacy.

She is the author of the 2017 book Can’t Just Stop: An Investigation of Compulsions; co-author (with Richard J. Davidson) of the 2012 book The Emotional Life of Your Brain; author of the 2007 book Train Your Mind, Change Your Brain; and co-author (with Jeffrey Schwartz) of the 2002 book The Mind and the Brain.

Presidents Council Events

presidents council
April 11 • 5 – 9 pm
Our fifth annual signature event features a panel of experts diving into the revolution of bioengineering made possible with CRISPR gene editing technology.
presidents council
February 27 • 6 – 8 pm
An exclusive screening of Nora Poggi’s groundbreaking film, She Started It, which sparks a critical discussion about young women entrepreneurs.
Article
In addition to NYSCI's annual gala, we have hosted and organized many unique events, inviting a diverse array of guests from the education, health and engineering sectors.